Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.

NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators

TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.

METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help

NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product

COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors

INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
ZEO ScientifiX Inc. Stock Analysis ZEOX
ZEO ScientifiX, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of degenerative diseases. The company is headquartered in Davie, Florida and currently employs 20 full-time employees. The company went IPO on 2013-11-08. The firm is primarily focused on developing innovative biological therapeutics for regenerative medicine and the treatment of degenerative diseases. Its proprietary products, including Zofin, which are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles, and Patient Pure X (PPX), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient’s own peripheral blood (RAAM Products). Its RAAM Products and related services are principally used in the health care industry administered through doctors and clinics. The company has developed and begun to distribute additional products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications and is actively exploring further development of additional products to be used in other topical aesthetic applications.
Read More ZEO ScientifiX Inc (ZEOX) Chart
Key Statistics of ZEO ScientifiX Inc (ZEOX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.32Volume
10.39KP/E Ratio (TTM)
-52 Week Range
Market Cap
13.61MAvg. Volume
4723.77Dividend Yield
-Financial Metrics & Statements of ZEO ScientifiX Inc (ZEOX)
FAQ's for ZEO ScientifiX Inc (ZEOX)
- According to Musaffa’s Shariah screening methodology, ZEO ScientifiX Inc (ZEOX) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ZEO ScientifiX Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in ZEO ScientifiX Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of ZEO ScientifiX Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of ZEO ScientifiX Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of ZEO ScientifiX Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.